{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T05:24:43Z","timestamp":1736918683302,"version":"3.33.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,14]]},"DOI":"10.7759\/cureus.77440","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T17:27:46Z","timestamp":1736875666000},"source":"Crossref","is-referenced-by-count":0,"title":["Neutrophil-to-Lymphocyte Ratio as a Biomarker for Motor Subtypes in Idiopathic Parkinson\u2019s Disease"],"prefix":"10.7759","author":[{"given":"Rashid","family":"Awan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Okasha","family":"Tahir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahzad","family":"Noor Ul Hadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wajeeh","family":"Ur Rehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahad","family":"Asim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-024-03887-7","article-title":"Association between neutrophil-to-lymphocyte ratio and motor subtypes in idiopathic Parkinson's disease: a prospective observational study","volume":"24","author":"Yi H","year":"2024","unstructured":"Yi H, Liang X, Xu F, et al.. Association between neutrophil-to-lymphocyte ratio and motor subtypes in idiopathic Parkinson's disease: a prospective observational study. BMC Neurol. 2024, 24:379. 10.1186\/s12883-024-03887-7","journal-title":"BMC Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-024-01256-y","article-title":"Role of NLRP3 inflammasome in central nervous system diseases","volume":"14","author":"Zhang L","year":"2024","unstructured":"Zhang L, Tang Y, Huang P, et al.. Role of NLRP3 inflammasome in central nervous system diseases. Cell Biosci. 2024, 14:75. 10.1186\/s13578-024-01256-y","journal-title":"Cell Biosci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2020.08.025","article-title":"Drd2 biased agonist prevents neurodegeneration against NLRP3 inflammasome in Parkinson's disease model via a \u03b2-arrestin2-biased mechanism","volume":"90","author":"Zhu J","year":"2020","unstructured":"Zhu J, Sun T, Zhang J, et al.. Drd2 biased agonist prevents neurodegeneration against NLRP3 inflammasome in Parkinson's disease model via a \u03b2-arrestin2-biased mechanism. Brain Behav Immun. 2020, 90:259-71. 10.1016\/j.bbi.2020.08.025","journal-title":"Brain Behav Immun"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S245928","article-title":"The Neutrophil to lymphocyte and lymphocyte to monocyte ratios as New prognostic factors in Hematological malignancies - a narrative Review","volume":"12","author":"Stefaniuk P","year":"2020","unstructured":"Stefaniuk P, Szymczyk A, Podhorecka M. The Neutrophil to lymphocyte and lymphocyte to monocyte ratios as New prognostic factors in Hematological malignancies - a narrative Review. Cancer Manag Res. 2020, 12:2961-77. 10.2147\/CMAR.S245928","journal-title":"Cancer Manag Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma RB","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, et al.. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2015, 30:1591-601. 10.1002\/mds.26424","journal-title":"Mov Disord"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2017.00216","article-title":"Brain and peripheral atypical inflammatory mediators potentiate neuroinflammation and neurodegeneration","volume":"11","author":"Kempuraj D","year":"2017","unstructured":"Kempuraj D, Thangavel R, Selvakumar GP, et al.. Brain and peripheral atypical inflammatory mediators potentiate neuroinflammation and neurodegeneration. Front Cell Neurosci. 2017, 11:216. 10.3389\/fncel.2017.00216","journal-title":"Front Cell Neurosci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1023\/a:1007074420772","article-title":"Inflammatory mediators and modulation of blood-brain barrier permeability","volume":"20","author":"Abbott NJ","year":"2000","unstructured":"Abbott NJ. Inflammatory mediators and modulation of blood-brain barrier permeability. Cell Mol Neurobiol. 2000, 20:131-47. 10.1023\/a:1007074420772","journal-title":"Cell Mol Neurobiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2024.1377994","article-title":"Association analysis of dopaminergic degeneration and the neutrophil-to-lymphocyte ratio in Parkinson's disease","volume":"16","author":"Zhang F","year":"2024","unstructured":"Zhang F, Chen B, Ren W, Yan Y, Zheng X, Jin S, Chang Y. Association analysis of dopaminergic degeneration and the neutrophil-to-lymphocyte ratio in Parkinson's disease. Front Aging Neurosci. 2024, 16:1377994. 10.3389\/fnagi.2024.1377994","journal-title":"Front Aging Neurosci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/003335490912400320","article-title":"OpenEpi: a web-based epidemiologic and statistical calculator for public health","volume":"124","author":"Sullivan KM","year":"2009","unstructured":"Sullivan KM, Dean A, Soe MM. OpenEpi: a web-based epidemiologic and statistical calculator for public health. Public Health Rep. 2009, 124:471-4. 10.1177\/003335490912400320","journal-title":"Public Health Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22340","article-title":"Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results","volume":"23","author":"Goetz CG","year":"2008","unstructured":"Goetz CG, Tilley BC, Shaftman SR, et al.. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008, 23:2129-70. 10.1002\/mds.22340","journal-title":"Mov Disord"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073636","article-title":"Neutrophil to lymphocyte ratio: an emerging marker of the relationships between the immune system and diseases","volume":"23","author":"Buonacera A","year":"2022","unstructured":"Buonacera A, Stancanelli B, Colaci M, Malatino L. Neutrophil to lymphocyte ratio: an emerging marker of the relationships between the immune system and diseases. Int J Mol Sci. 2022, 23:199-208. 10.3390\/ijms23073636","journal-title":"Int J Mol Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00622-7","article-title":"Neuropathology of incidental Lewy body & prodromal Parkinson's disease","volume":"18","author":"Koeglsperger T","year":"2023","unstructured":"Koeglsperger T, Rumpf SL, Schlie\u00dfer P, et al.. Neuropathology of incidental Lewy body & prodromal Parkinson's disease. Mol Neurodegener. 2023, 18:32. 10.1186\/s13024-023-00622-7","journal-title":"Mol Neurodegener"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1528-y","article-title":"Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease","volume":"16","author":"Lin CH","year":"2019","unstructured":"Lin CH, Chen CC, Chiang HL, et al.. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease. J Neuroinflammation. 2019, 16:129. 10.1186\/s12974-019-1528-y","journal-title":"J Neuroinflammation"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112137-20190702-01480","article-title":"Features of gut microbiota in patients with idiopathic Parkinson's disease (Article in Chinese)","volume":"100","author":"Li Y","year":"2020","unstructured":"Li Y, Li RX, Du YT, et al.. Features of gut microbiota in patients with idiopathic Parkinson's disease (Article in Chinese). Zhonghua Yi Xue Za Zhi. 2020, 100:1017-22. 10.3760\/cma.j.cn112137-20190702-01480","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-021-00427-6","article-title":"Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson's disease","volume":"16","author":"Aho VT","year":"2021","unstructured":"Aho VT, Houser MC, Pereira PA, et al.. Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson's disease. Mol Neurodegener. 2021, 16:6. 10.1186\/s13024-021-00427-6","journal-title":"Mol Neurodegener"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2016.12.015","article-title":"Evaluating the role of TMEM230 variants in Parkinson's disease","volume":"35","author":"Baumann H","year":"2017","unstructured":"Baumann H, Wolff S, M\u00fcnchau A, Hagenah JM, Lohmann K, Klein C. Evaluating the role of TMEM230 variants in Parkinson's disease. Parkinsonism Relat Disord. 2017, 35:100-1. 10.1016\/j.parkreldis.2016.12.015","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/314489-neutrophil-to-lymphocyte-ratio-as-a-biomarker-for-motor-subtypes-in-idiopathic-parkinsons-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T17:27:50Z","timestamp":1736875670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/314489-neutrophil-to-lymphocyte-ratio-as-a-biomarker-for-motor-subtypes-in-idiopathic-parkinsons-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,14]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.77440","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,14]]}}}